We have previously reported that PHD3 is needed for the hypoxic cell cycle to proceed over G1/S checkpoint [18] by reducing the stability of cyclin-dependent kinase inhibitor p27 in human carcinoma cells including ccRCC cells [19]. Here, EGLN3 is linked to nonpapillary renal cell carcinoma.